Transenterix Inc (NYSEAMERICAN:TRXC) shares gapped down before the market opened on Tuesday . The stock had previously closed at $2.42, but opened at $2.36. Transenterix shares last traded at $2.26, with a volume of 5006893 shares.

Several research analysts have recently weighed in on TRXC shares. Ladenburg Thalmann Financial Services set a $5.00 price target on Transenterix and gave the stock a “buy” rating in a research note on Friday, October 20th. Zacks Investment Research downgraded Transenterix from a “buy” rating to a “sell” rating in a research note on Tuesday, August 8th. Finally, Stifel Nicolaus reiterated a “buy” rating and set a $4.00 price target (up previously from $3.75) on shares of Transenterix in a research note on Monday, October 30th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and two have given a buy rating to the stock. Transenterix currently has a consensus rating of “Hold” and an average target price of $2.61.

In related news, CFO Joseph P. Slattery sold 333,000 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $2.93, for a total transaction of $975,690.00. Following the transaction, the chief financial officer now directly owns 440,974 shares of the company’s stock, valued at approximately $1,292,053.82. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Todd Pope sold 600,000 shares of the firm’s stock in a transaction dated Wednesday, October 18th. The shares were sold at an average price of $3.68, for a total value of $2,208,000.00. Following the transaction, the insider now directly owns 462,644 shares in the company, valued at $1,702,529.92. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,462,609 shares of company stock worth $4,666,595.

An institutional investor recently raised its position in Transenterix stock. Ladenburg Thalmann Financial Services Inc. increased its stake in shares of Transenterix Inc (NYSEAMERICAN:TRXC) by 87.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 79,150 shares of the medical instruments supplier’s stock after acquiring an additional 37,000 shares during the quarter. Ladenburg Thalmann Financial Services Inc. owned approximately 0.05% of Transenterix worth $113,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

ILLEGAL ACTIVITY NOTICE: This article was first published by Daily Political and is owned by of Daily Political. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The correct version of this article can be read at https://www.dailypolitical.com/2017/11/30/transenterix-trxc-shares-gap-down-to-2-36.html.

Transenterix Company Profile

TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.

Receive News & Ratings for Transenterix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix Inc and related companies with MarketBeat.com's FREE daily email newsletter.